Accelerate Diagnostics Inc (NASDAQ:AXDX)
| 0.608 Delayed Data As of 3:56pm ET |  +0.0442 / +7.84%Today’s Change | 0.50 Today|||52-Week Range 9.36 | -88.35% Year-to-Date |
Latest AXDX News | Press Releases
| Accelerate Diagnostics (AXDX) Reports Q1 Loss, Tops Revenue Estimates May 16 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 0.56 |
| Today’s open | 0.56 |
| Day’s range | 0.55 - 0.62 |
| Volume | 116,251 |
| Average volume (3 months) | 476,814 |
| Market cap | $44.3M |
Data as of 3:56pm ET, 05/27/2022
Growth & Valuation
| Earnings growth (last year) | +9.85% |
| Earnings growth (this year) | -45.18% |
| Earnings growth (next 5 years) | +4.00% |
| Revenue growth (last year) | +5.53% |
| P/E ratio | NM |
| Price/Sales | 27.35 |
| Price/Book | -- |
Competitors
Data as of 3:59pm ET, 05/27/2022
Financials
| Next reporting date | August 11, 2022 |
| EPS forecast (this quarter) | -$0.31 |
| Annual revenue (last year) | $11.8M |
| Annual profit (last year) | -$77.7M |
| Net profit margin | -659.50% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Tucson, Arizona |
Forecasts
